{"id":1068224,"date":"2022-05-23T01:48:17","date_gmt":"2022-05-23T05:48:17","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/positive-phase-3-study-with-aprocitentan-demonstrates-significant-antihypertensive-efficacy-in-patients-with-resistant-hypertension\/"},"modified":"2024-08-18T11:44:32","modified_gmt":"2024-08-18T15:44:32","slug":"positive-phase-3-study-with-aprocitentan-demonstrates-significant-antihypertensive-efficacy-in-patients-with-resistant-hypertension","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/positive-phase-3-study-with-aprocitentan-demonstrates-significant-antihypertensive-efficacy-in-patients-with-resistant-hypertension.php","title":{"rendered":"Positive Phase 3 study with aprocitentan demonstrates significant antihypertensive efficacy in patients with resistant hypertension"},"content":{"rendered":"<p><![CDATA[Ad hoc announcement pursuant to Art. 53 LR]]><\/p>\n<p>Continue reading here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/05\/23\/2448034\/0\/en\/Positive-Phase-3-study-with-aprocitentan-demonstrates-significant-antihypertensive-efficacy-in-patients-with-resistant-hypertension.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Positive Phase 3 study with aprocitentan demonstrates significant antihypertensive efficacy in patients with resistant hypertension\">Positive Phase 3 study with aprocitentan demonstrates significant antihypertensive efficacy in patients with resistant hypertension<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Continue reading here: Positive Phase 3 study with aprocitentan demonstrates significant antihypertensive efficacy in patients with resistant hypertension <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/positive-phase-3-study-with-aprocitentan-demonstrates-significant-antihypertensive-efficacy-in-patients-with-resistant-hypertension.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068224","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068224"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068224"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068224\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068224"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068224"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068224"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}